← 產業報告目錄
Biopharmaceutical Fermentation Market Size, Share & Trends Analysis Report By Product Type (Upstream Process, Downstream Products), By Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, Others), By End-Use, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-02頁數 180報告編號 INSIGHTACE-70bc599f68
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Biopharmaceutical Fermentation Market is projected to register a CAGR of 6.6%.
The Biopharmaceutical Fermentation sector involves key industry insights & findings from the report:
The surging emphasis of companies on creating innovative biological drugs is projected to drive the need for fermentation services and products, c. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is underpinned by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopharmaceutical Fermentation Market Snapshot
Chapter 4. Global Biopharmaceutical Fermentation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Upstream Process
5.2.1.1. Bioreactors/Fermenters
5.2.1.2. Bioprocess Analyzers
5.2.1.3. Process Monitoring System
5.2.1.4. Culture & Media Preparation
5.2.1.5. Other Upstream Products
5.2.2. Downstream Products
5.2.2.1. Filtration and Separation
5.2.2.2. Chromatography
5.2.2.3. Consumables and Accessories
5.2.2.4. Other Downstream Products
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Antibiotics
6.2.2. Recombinant Proteins
6.2.3. Monoclonal Antibodies
6.2.4. Probiotics
6.2.5. Others
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
7.2.1. Biopharmaceutical Industries
7.2.2. Contract Research Organization
7.2.3. Food Industries
7.2.4. Academic Research Institutes
7.2.5. Others
Chapter 8. Biopharmaceutical Fermentation Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Biopharmaceutical Fermentation Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
8.1.2. North America Biopharmaceutical Fermentation Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.3. North America Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.1.4. North America Biopharmaceutical Fermentation Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.2.2. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.2.3. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.2.4. Europe Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.3.2. Asia Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.3.3. Asia-Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.3.4. Asia Pacific Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.4.2. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.4.3. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.4.4. Latin America Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by Product Type, 2021-2034
8.5.2. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by Application, 2021-2034
8.5.3. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by End-user, 2021-2034
8.5.4. Middle East & Africa Biopharmaceutical Fermentation Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. GE Healthcare
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. Danaher Corporation
9.2.4. Sartorius Stedim Biotech
9.2.5. Merck KGaA
9.2.6. Eppendorf AG
9.2.7. Hoffmann-La Roche Ltd.
9.2.8. Nova Biomedicals
9.2.9. Lonza
9.2.10. Becton Dickinson and Company
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們